Momenta Pharmaceuticals, Inc. (MNTA)

[Bickema]

Synthon / Pfizer?

Its hard to get a read on where these two are with their generic being that generic copaxone isn't material for Pfizer and Synthon is private.

From Pfizer's Q416

Q: Can you also give us a roadmap for what biosimilar launches Pfizer might have in the next two to three years? And comment on your copaxone ANDA status in light of the legal ruling?

A: In the relatively near term, we anticipate that in the 2018, 2019 timeframe we'll be able to file around about five biosimilar products. I think you're aware of the products that we have in our pipeline.

Anyone have anything to add? Thanks